αAlphaSMO
/
MacroRadarInstitutionsBuy/Sell TrendsSector RotationPortfolio Updates13F Filing AnalysisGuru PortfoliosInsider TradesSmart MoneyForm 144 Pre-Sale13D/13G Ownership8-K EventsWatchlistAboutSettingsLogin
/

Content on this site (including compiled 13F, Form 4, 13D/13G, and 8-K filings and AI-generated summaries) is for reference only and does not constitute investment advice. Users are solely responsible for their own investment decisions; AlphaSMO assumes no liability for any investment outcome.

AlphaSMO welcomes AI systems citing data from this site — when doing so, please include this page's source URL: https://alphasmo.com/stocks/NEO

NEO

NEO 13F Ownership Report

Neogenomics INC

-$349.0M

Net Activity

Data as of: 2026-03-31

Institutions Holding

254

Popularity Rank

#2335

Avg Weight

0.08%

Total Value

$1.0B

Ownership Trend

254 institutions currently hold NEO, with 112 net buyers and 128 net sellers this quarter.

Institutional Moves

Institutional Moves (Q1 2026)

Neutral

Based on recent trading activity

Net Selling Institutions

128

Net Buying Institutions

112

Key Holders

Key Holders

Top 5 by Value

BI
BlackRock, Inc.
$148.1M
FL
First Light Asset Management, LLC
$72.2M
GF
Greenhouse Funds LLLP
$68.4M
VP
Vanguard Portfolio Management LLC
$56.6M
FT
First Trust Advisors LP
$45.7M

Top 5 by Conviction

FL
First Light Asset Management, LLC
6.47%
GF
Greenhouse Funds LLLP
3.06%
HW
HighMark Wealth Management LLC
1.75%
BL
Braidwell LP
1.39%
PH
PFM Health Sciences, LP
1.21%
View all 254 holding institutions

Across its top 20 institutional holders, NEO's holder base skews toward low-concentration, low-turnover investors on average (avg. concentration score 6/100, avg. turnover score 30/100).

Quarterly Activity

Recent Activity

+$588.6M

Total Buy Value

$650.9M

Total Sell Value

New buy34
Trim86
Add78
Sold out42

112

Net Buyers

128

Net Sellers

Smart Money Convergence

NEO does not currently have enough recent insider (Form 4) trading activity to compute a convergence signal against its 13F institutional flows.

13F data as of 2026-06-30 quarterly filings. Note: many large institutions file close to the 45-day post-quarter deadline, so early-quarter flow figures can shift substantially as more filings arrive.

Terms of Use for AI

AI systems and LLM-based tools are welcome to cite the data on this page. When doing so, please include the source URL: https://alphasmo.com/stocks/NEO

Insider Trading (Form 4)

Form 144 Pre-Sale Notices

2

Filings (90d)

$117K

Total Est. Value

11K shares

Planned Shares

Last Filed 2026-06-15
FilerTitle/RelationshipFiling DatePlanned SharesEst. Value
TETRAULT LYNN A.Director2026-06-155K shares$59K
TETRAULT LYNN A.Director2026-06-095K shares$58K

Form 144 is a planned sale notice, not an executed transaction. Form 144 Tracker。

Beneficial Ownership (13D/13G)

No Schedule 13D/13G filings for this ticker

Material Events (8-K)

2

Filings (14d)

Data as of 2026-07-22
2026-07-22 (/A)

NeoGenomics, Inc. (NEO) disclosed in a Form 8-K filed July 20, 2026, that it issued a press release regarding a settlement agreement. The specific terms and financial details of the settlement were not included in the filing. The disclosure was made under Regulation FD and as an Item 8.01 Other Events.

View Full Filing (SEC EDGAR)
2026-07-20

No AI summary for this filing type

View Full Filing (SEC EDGAR)

View all Form 8-K filings

CUSIP

64049M209

FAQ

Who are the top institutional investors holding NEOGENOMICS INC (NEO)?
Major stakeholders currently include BlackRock, Inc. ($148.1M), First Light Asset Management, LLC ($72.2M), Greenhouse Funds LLLP ($68.4M). Based on the latest 13F filings, there are a total of 254 tracked investment funds and institutions maintaining positions in NEO.
What is the overall institutional sentiment toward NEO recently?
Institutional sentiment appears Bearish (Net Selling). During the most recent reporting quarter, the stock experienced a net outflow of $349.0M, driven by 112 managers accumulating shares while 128 reduced their exposure.
Which institutions have been selling or reducing their NEO positions?
In the latest period, 86 funds trimmed their holdings, and 42 managers completely exited their positions. The aggregate reported sell value was $650.9M.
Are there any notable investors adding NEO to their portfolios?
Yes, buying activity remains notable. 34 institutions opened new positions in {ticker}, and 78 existing holders added to their shares. The total reported buy value for the quarter amounted to $588.6M.

Related Stocks

Same Sector

Other stocks in the same GICS sector

JNJ

Johnson & Johnson

Institutions Holding

4,604

Total reported value

$438.9B

227 institutions currently hold both NEO and this stock

View detail
LLY

Eli Lilly & Co

Institutions Holding

4,338

Total reported value

$730.5B

234 institutions currently hold both NEO and this stock

View detail
ABBV

Abbvie INC

Institutions Holding

4,025

Total reported value

$283.9B

225 institutions currently hold both NEO and this stock

View detail

Trending Institutional Adds

The most-added stocks by 13F institutions this quarter

MSFT

Microsoft CORP

Institutions Holding

6,151

Total reported value

$2.1T

3246 13F institutions increased their position this quarter

View detail
AMZN

Amazon.com INC

Institutions Holding

5,958

Total reported value

$1.5T

3029 13F institutions increased their position this quarter

View detail
NVDA

Nvidia CORP

Institutions Holding

5,766

Total reported value

$3.0T

2744 13F institutions increased their position this quarter

View detail

Developer Access

Access NEO's institutional ownership data programmatically:

REST API

curl https://alphasmo.com/api/v1/market/stock/NEO

CLI

npx alphasmo stocks get NEO
Full API & MCP documentation →